Sign in

CIK 0001894562 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Prime Medicine, Inc.

Sign in to watch
Ticker
PRME
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-465-0013
Business address
60 FIRST ST., CAMBRIDGE, MA, 02141
  1. 4 Planned sale 10% owner sold 65,649 shares at an average $12.63 ($829,275)
  2. 4 Planned sale 10% owner sold 185,242 shares at an average $12.74 ($2,359,309)
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4 Planned sale 10% owner sold 114,023 shares at an average $13.82 ($1,575,337)
  6. 4 Planned sale 10% owner sold 422,010 shares at an average $14.09 ($5,946,340)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Open-market buy 10% owner bought 800,000 shares at $17.00 ($13,600,000)
  16. 4 Open-market buy 10% owner bought 800,000 shares at $17.00 ($13,600,000)
  17. 4 Open-market buy Director bought 800,000 shares at $17.00 ($13,600,000)
  18. 4 Conversion 10% owner acquired 321,665 shares (conversion)
  19. 4 Open-market buy Director bought 400,000 shares at $17.00 ($6,800,000)
  20. 4 Conversion See Remark 1 acquired 8,462,946 shares (conversion)

Page 6 of 7 · 140 filings